{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:28:16Z","timestamp":1790663296566,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd000140","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2010,12,8]],"date-time":"2010-12-08T00:00:00Z","timestamp":1291766400000}}],"reference-count":24,"publisher":"Wiley","issue":"3","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd000140.pub2","type":"journal-article","created":{"date-parts":[[2011,1,6]],"date-time":"2011-01-06T05:35:59Z","timestamp":1294292159000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Methylxanthine treatment for apnoea in preterm infants"],"prefix":"10.1002","volume":"2013","author":[{"given":"David J","family":"Henderson-Smart","sequence":"first","affiliation":[{"name":"Faculty of Medicine, University of Sydney; (Deceased) Central Clinical School; Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio G","family":"De Paoli","sequence":"additional","affiliation":[{"name":"Royal Hobart Hospital; Department of Paediatrics; GPO Box 1061 Hobart Tasmania Australia 7001"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,12,8]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD000140.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jpeds.2009.09.069","article-title":"Caffeine for Apnea of Prematurity trial: benefits may vary in subgroups","volume":"156","author":"Davis","year":"2010","journal-title":"Journal of Pediatrics"},{"issue":"20","key":"10.1002\/14651858.CD000140.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1056\/NEJMoa054065","article-title":"Caffeine therapy for apnea of prematurity","volume":"354","author":"Schmidt","year":"2006","journal-title":"New England Journal of Medicine"},{"issue":"19","key":"10.1002\/14651858.CD000140.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa073679","article-title":"Long-term effects of caffeine therapy for apnea of prematurity","volume":"357","author":"Schmidt","year":"2007","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD000140.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"172A","DOI":"10.1203\/00006450-199804001-01022","article-title":"Results of the first double blind placebo (PL) controlled study of caffeine citrate (CC) for the treatment of apnea of prematurity (AOP)","volume":"43","author":"Erenberg","year":"1998","journal-title":"Pediatric Research"},{"issue":"6","key":"10.1002\/14651858.CD000140.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1592\/phco.20.7.644.35167","article-title":"Caffeine citrate for the treatment of apnea of prematurity: a double-blind placebo-controlled study","volume":"20","author":"Erenberg","year":"2000","journal-title":"Pharmacotherapy"},{"issue":"4","key":"10.1002\/14651858.CD000140.pub2-BIB0006|cit6","first-page":"290","article-title":"Theophylline in treatment of apnoea of prematurity","volume":"17","author":"Gupta","year":"1981","journal-title":"Australian Paediatric Journal"},{"issue":"6","key":"10.1002\/14651858.CD000140.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S0022-3476(81)80038-8","article-title":"The efficacy of caffeine in the treatment of recurrent idiopathic apnea in premature infants","volume":"99","author":"Murat","year":"1981","journal-title":"Journal of Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD000140.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0022-3476(05)81620-8","article-title":"A blinded, randomized, placebo-controlled trial to compare theophylline and doxapram for the treatment of apnea of prematurity","volume":"116","author":"Peliowski","year":"1990","journal-title":"Journal of Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD000140.pub2-BIB0009|cit9","first-page":"567","article-title":"Limitations of theophylline in the treatment of apnea of prematurity","volume":"139","author":"Sims","year":"1985","journal-title":"American Journal of Diseases of Children"},{"issue":"6","key":"10.1002\/14651858.CD000140.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/FTD.0b013e3181898b6f","article-title":"Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring","volume":"30","author":"Charles","year":"2008","journal-title":"Therapeutic Drug Monitoring"},{"issue":"4","key":"10.1002\/14651858.CD000140.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/sj.jp.7210737","article-title":"A randomized, controlled, double-blind trial comparing two loading doses of aminophylline","volume":"22","author":"Hochwald","year":"2002","journal-title":"Journal of Perinatology"},{"issue":"4 Pt 1","key":"10.1002\/14651858.CD000140.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1542\/peds.111.4.914","article-title":"Apnea, sudden infant death syndrome, and home monitoring","volume":"111","author":"Committee on Fetus and Newborn. American Academy of Pediatrics","year":"2003","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD000140.pub2-BIB0013|cit13","first-page":"352","article-title":"Pharmacotherapy of respiratory control disorders","volume-title":"Respiratory Control Disorders in Infants and Children","author":"Blanchard","year":"1992"},{"issue":"1","key":"10.1002\/14651858.CD000140.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2165\/00128072-200103010-00005","article-title":"Caffeine citrate: a review of its use in apnoea of prematurity","volume":"3","author":"Comer","year":"2001","journal-title":"Paediatric Drugs"},{"issue":"1","key":"10.1002\/14651858.CD000140.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1046\/j.1440-1754.2000.00446.x","article-title":"Methylxanthines and sensorineural outcome at 14 years in children < 1501 g birthweight","volume":"36","author":"Davis","year":"2000","journal-title":"Journal of Paediatrics and Child Health"},{"issue":"1","key":"10.1002\/14651858.CD000140.pub2-BIB0016|cit16","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000139","article-title":"Prophylactic methylxanthine for extubation in preterm infants","author":"Henderson-Smart","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD000140.pub2-BIB0017|cit17","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000432","article-title":"Prophylactic methylxanthine for the prevention of apnea in preterm infants","author":"Henderson-Smart","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000140.pub2-BIB0018|cit18","doi-asserted-by":"crossref","DOI":"10.1002\/9780470987384.ch47","article-title":"Recurrent apnoea","volume-title":"Evidence Based Pediatrics","author":"Henderson-Smart","year":"2004"},{"issue":"4","key":"10.1002\/14651858.CD000140.pub2-BIB0019|cit19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000273","article-title":"Caffeine vs theophylline treatment for apnea in preterm infants","author":"Steer","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD000140.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S0022-3476(98)70297-5","article-title":"Neonatal apnea, bradycardia, or desaturation: does it Matter?","volume":"132","author":"Martin","year":"1998","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD000140.pub2-BIB0021|cit21","first-page":"385","article-title":"Recurrent apnea","volume-title":"Effective Care of the Newborn Infant","author":"Samuels","year":"1992"},{"issue":"4","key":"10.1002\/14651858.CD000140.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0022-3476(99)70180-0","article-title":"Methylxanthine therapy in premature infants: sound practice, disaster or fruitless byway?","volume":"135","author":"Schmidt","year":"1999","journal-title":"Journal of Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD000140.pub2-BIB0023|cit23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000140","article-title":"Methylxanthine for apnea in preterm infants","author":"Henderson-Smart","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD000140.pub2-BIB0024|cit24","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000140","article-title":"Methylxanthine treatment for apnea in preterm infants","author":"Henderson-Smart","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD000140.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T10:01:57Z","timestamp":1737540117000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD000140.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Neonatal Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,12,8]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,3]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000140.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,8]]}}}